Arch Therapeutics Inc (ARTH) financial statements (2020 and earlier)

Company profile

Business Address 235 WALNUT STREET, SUITE 6
FRAMINGHAM, MA 01702
State of Incorp. NV
Fiscal Year End September 30
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2019
TTM
9/30/2019
9/30/2018
9/30/2017
9/30/2016
9/30/2015
9/30/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments3,0232,1804,6675,9945,0363,960834
Cash and cash equivalents3,0232,1804,6675,9945,0363,960834
Inventory, net of allowances, customer advances and progress billings200347     
Inventory200347     
Prepaid expense  152    
Other undisclosed current assets330363 851084343
Total current assets:3,5532,8904,8196,0795,1444,003877
Noncurrent Assets
Property, plant and equipment109177442
Other noncurrent assets4444   
Other undisclosed noncurrent assets    (4)(4)(2)
Total noncurrent assets:13132111   
TOTAL ASSETS:3,5662,9024,8406,0905,1444,003877
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities402534161265680232176
Accounts payable402534161265375232176
Interest and dividends payable    305  
Debt    900474 
Derivative instruments and hedges, liabilities     3352,280
Other undisclosed current liabilities230180127169299245268
Total current liabilities:6317142884341,8791,2862,724
Noncurrent Liabilities
Long-term debt and lease obligation    78967956
Long-term debt, excluding current maturities    78967956
Liabilities, other than long-term debt3,0362,9963,1923,430262104,090
Accounts payable and accrued liabilities    26210100
Derivative instruments and hedges, liabilities3,0362,9963,1923,430  3,990
Total noncurrent liabilities:3,0362,9963,1923,4301041,1775,046
Total liabilities:3,6673,7103,4803,8641,9832,4637,769
Stockholders' equity
Stockholders' equity attributable to parent(101)(807)1,3602,2273,1611,540(6,892)
Common stock18717316015013410772
Additional paid in capital40,23737,88535,51731,58024,74117,1555,810
Accumulated deficit(40,525)(38,865)(34,317)(29,503)(21,715)(15,722)(12,775)
Total stockholders' equity:(101)(807)1,3602,2273,1611,540(6,892)
TOTAL LIABILITIES AND EQUITY:3,5662,9024,8406,0905,1444,003877

Income statement (P&L) ($ in thousands)

12/31/2019
TTM
9/30/2019
9/30/2018
9/30/2017
9/30/2016
9/30/2015
9/30/2014
Operating expenses(6,224)(6,372)(7,450)(7,303)(6,051)(5,461)(4,612)
Operating loss:(6,224)(6,372)(7,450)(7,303)(6,051)(5,461)(4,612)
Interest and debt expense   (131)(277)(378)(111)
Net loss:(6,224)(6,372)(7,450)(7,434)(6,327)(5,838)(4,723)
Other undisclosed net income (loss) attributable to parent2,6161,8242,636(355)3352,891(3,420)
Net loss available to common stockholders, diluted:(3,607)(4,548)(4,814)(7,789)(5,992)(2,948)(8,143)

Comprehensive Income ($ in thousands)

12/31/2019
TTM
9/30/2019
9/30/2018
9/30/2017
9/30/2016
9/30/2015
9/30/2014
Net loss:(6,224)(6,372)(7,450)(7,434)(6,327)(5,838)(4,723)
Comprehensive loss, net of tax, attributable to parent:(6,224)(6,372)(7,450)(7,434)(6,327)(5,838)(4,723)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: